Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs
- 31 December 1987
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 33 (1), 139-144
- https://doi.org/10.1016/0163-7258(87)90042-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- PRECURSOR PROTHROMBIN STATUS IN PATIENTS RECEIVING ANTICONVULSANT DRUGSThe Lancet, 1985
- A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.British Journal of Clinical Pharmacology, 1984
- Decreased serum 24, 25‐dihydroxyvitamin D concentration during long‐term anticonvulsant therapy in adult epilepticsAnnals of Neurology, 1982
- Clinical Implications of Enzyme Induction and Enzyme InhibitionClinical Pharmacokinetics, 1981
- Effect of phenytoin on bone and vitamin D metabolismAnnals of Neurology, 1979
- The effects of chronic drug administration on hepatic enzyme induction and folate metabolism.British Journal of Clinical Pharmacology, 1978
- Plasma 1,25-Dihydroxyvitamin D Levels in Patients Receiving Anticonvulsant DrugsJournal of Clinical Endocrinology & Metabolism, 1977
- Fatal Neonatal Hemorrhage After Maternal Anticonvulsant TherapyPublished by American Medical Association (AMA) ,1976
- Bone Complications of AnticonvulsantsDrugs, 1976
- Disturbance of Calcium Metabolism by Anticonvulsant DrugsBMJ, 1970